IMMUNOSUPPRESSIVE THERAPY AFTER LIVER TRANSPLANTATION AND PREVENTION OF REJECTION SYNDROME
loading.default
item.page.date
item.page.journal-title
item.page.journal-issn
item.page.volume-title
item.page.publisher
Modern American Journals
item.page.abstract
Background: Liver transplantation (LT) is a life-saving procedure for patients with end-stage liver disease and hepatocellular carcinoma. Long-term survival and graft function depend largely on effective immunosuppressive therapy. However, clinical practice varies widely across Western, Asian, and resource-limited countries due to differences in epidemiology, donor sources, healthcare infrastructure, and drug availability.